Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Shionogi Pharmaceutical Technology Limited is an active wholly owned subsidiary of Japan’s major pharma firm, Shionogi & Co., Ltd. Its primary function is to provide clinical development support and facilitate sales operations within mainland China for drugs developed by its parent organization. The company does not maintain its own R&D portfolio but instead enables registration trials, regulatory submissions, market access strategies, and post-marketing activities tailored to Chinese healthcare regulations—a vital link in bringing innovative therapies from the global group into one of Asia’s largest markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Shennuoji Pharmaceutical Technology.